Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

SUANNUTRA USA Seals US Distribution Rights for TetraSOD®


News provided by

SuanNutra USA

May 13, 2026, 07:00 ET

Share this article

Share toX

Share this article

Share toX

Science-backed marine bioactive complex developed by Fitoplancton Marino, recognized for its clinically supported benefits in cellular and metabolic health

Key Takeaways

  • The agreement grants SUANNUTRA USA commercial distribution rights for TetraSOD® in the US market.
  • TetraSOD® is a patented, bioactive marine formulation designed to support cellular and metabolic health.
  • TetraSOD® is sustainably sourced and manufactured. The strain was isolated in Doñana Natural Park, which is one of Europe's most important protected wetlands, with a unique biodiversity. The ingredient is cultivated and harvested in closed, outdoor bioreactors.
  • TetraSOD® is backed by more than a dozen peer-reviewed studies.

GLEN ROCK, N.J., May 13, 2026 /PRNewswire/ -- Nutraceutical ingredients innovator SUANNUTRA USA announces it has inked a distribution agreement with Spanish biotech company Fitoplancton Marino, S.L. to provide TetraSOD® for the North American market.

Continue Reading
SUANNUTRA USA Seals US Distribution Rights for TetraSOD® (Credit: Fitoplancton Marino) (PRNewsfoto/SuanNutra USA)
SUANNUTRA USA Seals US Distribution Rights for TetraSOD® (Credit: Fitoplancton Marino) (PRNewsfoto/SuanNutra USA)

TetraSOD® is a science-backed bioactive marine complex designed to support cellular and metabolic health, with demonstrated benefits in body composition and energy metabolism. This patented ingredient, derived from the microalgae Tetraselmis chuii, delivers high enzymatic activity alongside a diverse matrix of bioactive compounds. In addition to its high superoxide dismutase (SOD) activity, TetraSOD® contains natural polyunsaturated fatty acids (PUFAs), vitamins, carotenoids, polyphenols, and phytosterols contributing to its broad biological activity.

While SOD plays a central role in the body's antioxidant defense system, TetraSOD® goes beyond conventional antioxidant supplementation by acting as an indirect antioxidant, activating the body's endogenous defense and adaptive response mechanisms. Cellular health is foundational to the function of tissues, organs, and physiological systems, influencing metabolism, immune function, and physical performance.

Tetraselmis chuii was first identified in the 1950s and has long been used in aquaculture due to its rich nutritional profile, "We invested more than 20 years in developing the ingredient, revealing the science behind the ingredient's action, and obtaining the regulatory approvals in many countries. Now, everything is aligned for consumers to enjoy TetraSOD®'s benefits and adopt the mindset of agelessness," says Carlos Unamunzaga, CEO of Fitoplancton Marino.

Micro-Algae, Macro Benefits

Fitoplancton Marino developed a patented production method employing sustainable practices to maximize the content of SOD, lipids, and other key components of these super microalgae.

The phytoplankton is cultivated and harvested in closed outdoor bioreactors in El Puerto de Santa Maria, near the Spanish coast. This patent-protected technology enables cultivation under controlled temperature, oxygen levels, stressors, and nutrients to increase the concentration of SOD to a record-breaking minimum of 30,000 µ/g. No extraction is involved; the powerful microalgae is simply harvested and dried into a fine, pale-green powder.

"TetraSOD® represents a strong addition to SUANNUTRA USA's portfolio of science-backed ingredients," said Anthony Weston, CEO of SUANNUTRA. "With its solid clinical evidence, low effective dose, and benefits that were perceived by subjects in under a month, we believe TetraSOD® has the potential to become a true hero ingredient in the US market. Its unique marine origin and sustainable production further reinforce its differentiation in a highly competitive, yet fast-growing market—particularly across metabolic health, performance, and healthy ageing categories."

17 studies, 10 patents, multiple awards

TetraSOD® is safeguarded by 10 patents and backed by 17 peer-reviewed studies conducted since 2006, with the latest published in March 2026. Its efficacy at a daily dose of just 25 mg has been demonstrated in multiple human clinical trials, highlighting its potency compared to conventional nutritional ingredients.

Clinical and preclinical research supports TetraSOD® across three key areas:

• Metabolic health and body composition
• Physical performance and recovery
• Cellular and systemic health

In human clinical studies, supplementation with TetraSOD® was associated with improvements in aerobic capacity, oxygen uptake (VO2 max), and recovery markers after only 14 days usage.

"Additional studies have demonstrated TetraSOD®'s role in supporting post-workout muscle recovery, noting its ability to reduce muscle damage," contributes Marián Gutiérrez Montero, Business Development Director of SUANNUTRA. "According to a couple of preclinical studies, the daily ingestion of TetraSOD® reduced markers associated with oxidative stress and inflammation, and most recently we uncovered evidence of its potential role as a prebiotic."

A lab study published last year in the journal Foods illustrated the ingredient's ability to increase microbial diversity in the colon, favoring the growth of beneficial bacteria over pathogenic strains, and inducing the production of short-chain fatty acids, particularly butyrate. Research published last March also demonstrates TetraSOD®'s ability to protect telomere length in human cells, supporting its potential role in healthy ageing.

"This micro-seaweed's wellness attributes are proving to be diverse and all-encompassing and already feature in a full spectrum of supplement formulations targeting healthy ageing, sports and active nutrition, GLP-1 support, and cellular health," adds Gutiérrez Montero.

A central mechanism of TetraSOD®'s action, highlighted in multiple preclinical and clinical studies, is its ability to activate NRF2 and SIRT1 pathways. NRF2 is a key transcription factor involved in the cellular antioxidant response, while SIRT1, a member of the sirtuin family, plays an important role in cellular protection and repair. Together, these pathways help protect cells against oxidative stress, inflammation, toxins, and environmental stressors, while also supporting cellular repair mechanisms.

TetraSOD® is a rigorously tested ingredient and adheres to the stringent Asian, EU, US, and Canadian quality standards. It has won multiple awards and holds Novel Food approval in EU, self-GRAS in US, a Natural Product Number (NPN) in Canada. TetraSOD® recently became a top seller in Japan.

Press contact

NutriPR
Liat Simha
Tel: +972-9-9742893
E-mail: [email protected] 
Website: www.nutripr.com

Company contact

SUANNUTRA USA
Marián Gutiérrez Montero 
Business Development Director
E-mail: info@suannutra.com
Website: www.suannutra.com

Photo - https://mma.prnewswire.com/media/2978997/Distribution_Rights_TetraSOD.jpg

SOURCE SuanNutra USA

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.